| Company | Date | Position | Consensus ⓘ | Price Target ⓘ | 1-Yr Return |
|---|---|---|---|---|---|
|
PVLA
Palvella Therapeutics
|
May 20, 2026 | BUY |
Strong Buy
+13.2% avg upside
27 analysts
|
$240.00
63.52% Upside
|
+27.1% |
|
IMRX
Immuneering
|
May 19, 2026 | BUY |
Strong Buy
+243.2% avg upside
10 analysts
|
$20.00
285.34% Upside
|
+3.3% |
|
IMTX
Immatics
|
May 19, 2026 | BUY |
Strong Buy
+83.6% avg upside
15 analysts
|
$25.00
151.16% Upside
|
· |
|
TNYA
Tenaya Therapeutics
|
May 15, 2026 | BUY |
Strong Buy
+1174.3% avg upside
11 analysts
|
$8.00
916.56% Upside
|
+0.0% |
|
SNTI
Senti Biosciences
|
May 15, 2026 | BUY |
Strong Buy
+717.7% avg upside
7 analysts
|
$12.00
1021.44% Upside
|
-5.9% |
|
SLDB
Solid Biosciences
|
May 13, 2026 | BUY |
Strong Buy
+46.2% avg upside
23 analysts
|
$15.00
38.47% Upside
|
+36.6% |
|
MGX
Metagenomi, Inc.
|
May 13, 2026 | BUY |
Strong Buy
+693.6% avg upside
7 analysts
|
$7.00
455.52% Upside
|
-9.4% |
|
LXEO
Lexeo Therapeutics, Inc.
|
May 11, 2026 | BUY |
Strong Buy
+312.9% avg upside
11 analysts
|
$17.00
262.47% Upside
|
-16.8% |
|
RCKT
Rocket Pharmaceuticals
|
May 10, 2026 | BUY |
Buy
+329.4% avg upside
29 analysts
|
$11.00
186.37% Upside
|
-17.5% |
|
PRME
Prime Medicine, Inc.
|
May 08, 2026 | BUY |
Strong Buy
+152.4% avg upside
16 analysts
|
$9.00
132.52% Upside
|
+16.0% |
|
FDMT
4D Molecular Therapeutics
|
May 08, 2026 | BUY |
Strong Buy
+171.4% avg upside
15 analysts
|
$26.00
100.09% Upside
|
-9.8% |
|
IOVA
Iovance Biotherapeutics
|
May 07, 2026 | BUY |
Buy
+195.5% avg upside
24 analysts
|
$14.00
224.82% Upside
|
-2.8% |
|
TSHA
Taysha Gene Therapies
|
May 06, 2026 | BUY |
Strong Buy
+111.0% avg upside
21 analysts
|
$12.00
83.76% Upside
|
-6.5% |
|
CLYM
Climb Bio
|
May 05, 2026 | BUY |
Strong Buy
+40.1% avg upside
18 analysts
|
$22.00
70.56% Upside
|
-5.7% |
|
EDIT
Editas Medicine
|
May 05, 2026 | BUY |
Buy
+274.4% avg upside
33 analysts
|
$4.00
9.64% Upside
|
-13.0% |
|
KRYS
Krystal Biotech
|
May 04, 2026 | BUY |
Strong Buy
-33.4% avg upside
19 analysts
|
$323.00
13.96% Downside
|
+30.7% |
|
CRSP
Crispr Therapeutics AG
|
May 04, 2026 | BUY |
Buy
+25.2% avg upside
41 analysts
|
$76.00
26.41% Upside
|
+12.1% |
|
NTLA
Intellia Therapeutics
|
Apr 27, 2026 | BUY |
Buy
+124.8% avg upside
37 analysts
|
$30.00
70.77% Upside
|
+34.7% |
|
PASG
Passage Bio
|
Nov 12, 2025 | BUY |
Buy
+275.1% avg upside
14 analysts
|
$21.00
348.73% Upside
|
-45.4% |
|
MRNA
Moderna
|
Oct 07, 2025 | HOLD |
Hold
-13.7% avg upside
38 analysts
|
— | +191.7% |
|
FR:ALSEN
Sensorion SAS
|
Sep 17, 2025 | BUY |
Strong Buy
+550.9% avg upside
5 analysts
|
$1.00
284.58% Upside
|
· |
|
IPSC
Century Therapeutics
|
Mar 24, 2025 | BUY |
Strong Buy
+119.2% avg upside
11 analysts
|
$7.00
188.16% Upside
|
+283.6% |
|
ABUS
Arbutus Biopharma
|
Jan 29, 2024 | BUY |
Strong Buy
+81.4% avg upside
15 analysts
|
— | +33.1% |
|
MGTX
Meiragtx Holdings
|
Dec 21, 2023 | BUY |
Strong Buy
+87.4% avg upside
13 analysts
|
$36.00
158.70% Upside
|
-5.5% |
|
QURE
uniQure
|
Aug 25, 2023 | BUY |
Strong Buy
+41.3% avg upside
29 analysts
|
— | -27.8% |
|
CABA
Cabaletta Bio
|
Mar 21, 2023 | BUY |
Strong Buy
+336.2% avg upside
16 analysts
|
$12.00
276.16% Upside
|
+126.9% |
|
PDSB
PDS Biotechnology
|
Feb 17, 2023 | HOLD |
Strong Buy
+1683.4% avg upside
11 analysts
|
— | -38.7% |
|
GYRE
Gyre Therapeutics
|
Jan 06, 2023 | HOLD |
Strong Buy
+165.6% avg upside
15 analysts
|
— | +298.6% |
|
PAGS
Pagseguro Digital
|
Dec 14, 2022 | BUY |
Buy
+54.9% avg upside
18 analysts
|
$11.00
20.54% Upside
|
+33.7% |
|
SQZB
SQZ Biotechnologies
|
Dec 01, 2022 | BUY |
Buy
+102677.7% avg upside
7 analysts
|
$40.00
166566.59% Upside
|
-98.7% |
|
FR:SIGHT
GenSight Biologics SA
|
Jul 28, 2022 | BUY |
Strong Buy
+17972.3% avg upside
3 analysts
|
$15.00
17972.28% Upside
|
· |
|
RGNX
RegenXBio
|
Mar 29, 2022 | BUY |
Strong Buy
+184.4% avg upside
22 analysts
|
$76.00
472.20% Upside
|
-43.2% |
|
VYGR
Voyager Therapeutics
|
Mar 09, 2022 | HOLD |
Strong Buy
+279.0% avg upside
23 analysts
|
$6.00
58.66% Upside
|
+25.6% |
|
QTTB
Q32 Bio
|
Feb 22, 2022 | BUY |
Buy
+304.7% avg upside
24 analysts
|
$15.00
14.55% Upside
|
-48.5% |
|
IMVT
Immunovant
|
Jan 05, 2022 | BUY |
Strong Buy
-0.4% avg upside
24 analysts
|
$20.00
48.38% Downside
|
+146.4% |
|
IMNM
Immunome
|
Aug 20, 2021 | BUY |
Strong Buy
+43.3% avg upside
16 analysts
|
$21.00
11.00% Downside
|
-58.0% |
|
NTBLQ
Notable Labs
|
Jul 30, 2021 | HOLD |
Buy
+809999900.0% avg upside
12 analysts
|
— | · |
|
REPL
Replimune Group
|
Oct 14, 2020 | BUY |
Buy
+77.5% avg upside
13 analysts
|
$48.00
314.60% Upside
|
-14.2% |
|
NAUT
Nautilus Biotechnolgy
|
Jun 04, 2020 | BUY |
Strong Buy
+564.8% avg upside
5 analysts
|
$28.00
1518.50% Upside
|
-3.1% |
|
FBRX
Forte Biosciences
|
Feb 20, 2020 | HOLD |
Strong Buy
+94.5% avg upside
14 analysts
|
$1.00
95.30% Downside
|
+139.8% |
Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.